Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects
暂无分享,去创建一个
Chunling Zhang | Raymond Carroll | J. Holst | An Zhou | Xiaorong Zhu | D. Steiner | I. Lindberg | A. Dey | Jens J Holst | Xiaorong Zhu | An Zhou | Arunangsu Dey | Christina Norrbom | Virginie Laurent | Iris Lindberg | Randi Ugleholdt | Donald F Steiner | R. Carroll | V. Laurent | C. Norrbom | R. Ugleholdt | Chunling Zhang | Christina Norrbom | Randi Ugleholdt
[1] L. Orci,et al. Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice* , 2001, The Journal of Biological Chemistry.
[2] N. Seidah,et al. Gene organization of the mouse pro-hormone and pro-protein convertase PC1. , 1994, DNA and cell biology.
[3] L. Orci,et al. Incomplete Processing of Proinsulin to Insulin Accompanied by Elevation of Des-31,32 Proinsulin Intermediates in Islets of Mice Lacking Active PC2* , 1998, The Journal of Biological Chemistry.
[4] E. Simpson,et al. Impaired fertility in mice deficient for the testicular germ-cell protease PC4. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Mains,et al. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. , 1993, The Journal of biological chemistry.
[6] T. Watanabe,et al. Consensus sequence for precursor processing at mono-arginyl sites. Evidence for the involvement of a Kex2-like endoprotease in precursor cleavages at both dibasic and mono-arginyl sites. , 1992, The Journal of biological chemistry.
[7] N. Seidah,et al. The isoforms of proprotein convertase PC5 are sorted to different subcellular compartments , 1996, The Journal of cell biology.
[8] A. Viale,et al. Cellular Localization and Role of Prohormone Convertases in the Processing of Pro-melanin Concentrating Hormone in Mammals* , 1999, The Journal of Biological Chemistry.
[9] J. Holst,et al. Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans , 1994, Diabetes.
[10] S. O’Rahilly,et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.
[11] D. Steiner,et al. Specificity of Prohormone Convertase 2 on Proenkephalin and Proenkephalin-related Substrates* , 1998, The Journal of Biological Chemistry.
[12] D. Constam,et al. Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin. , 1998, Development.
[13] L. Orci,et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Steiner,et al. Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like Peptide (*) , 1995, The Journal of Biological Chemistry.
[15] S. Shoelson,et al. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing. , 1992, The Journal of biological chemistry.
[16] L. Orci,et al. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] L. Muller,et al. The cell biology of the prohormone convertases PC1 and PC2. , 1999, Progress in nucleic acid research and molecular biology.
[18] A. Joyner,et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.
[19] I. Lindberg,et al. Prodynorphin Processing by Proprotein Convertase 2 , 1998, The Journal of Biological Chemistry.
[20] E. Nillni,et al. Posttranslational Processing of Progrowth Hormone-Releasing Hormone1. , 1999, Endocrinology.
[21] An Zhou,et al. Proteolytic Processing in the Secretory Pathway* , 1999, The Journal of Biological Chemistry.
[22] P. Leder,et al. The Neuroendocrine Protein 7B2 Is Required for Peptide Hormone Processing In Vivo and Provides a Novel Mechanism for Pituitary Cushing’s Disease , 1999, Cell.
[23] E. Eicher,et al. Stimulation of growth in the little mouse. , 1976, The Journal of endocrinology.
[24] A. Arimura,et al. Prohormone Convertase PC4 Processes the Precursor of PACAP in the Testis , 2000, Annals of the New York Academy of Sciences.
[25] N. Miki,et al. Hypothalamic growth hormone-releasing factor (GRF) participates in the negative feedback regulation of growth hormone secretion. , 1989, Life sciences.
[26] A. Grüters,et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.
[27] D. Steiner,et al. Mortality in 7B2 null mice can be rescued by adrenalectomy: Involvement of dopamine in ACTH hypersecretion , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Polonskaia,et al. Defective Prodynorphin Processing in Mice Lacking Prohormone Convertase PC2 , 2000, Journal of neurochemistry.
[29] D. Drucker. Glucagon-like peptide 2. , 1997, The Journal of clinical endocrinology and metabolism.
[30] J. Dixon,et al. Purification and characterization of the candidate prohormone-processing enzyme SPC3 produced in a mouse L cell line. , 1993, The Journal of biological chemistry.
[31] Aldons J. Lusis,et al. Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.
[32] J. Holst,et al. Structure, measurement, and secretion of human glucagon-like peptide-2 , 2000, Peptides.
[33] M. Thorner,et al. The Mutant Growth Hormone-Releasing Hormone (GHRH) Receptor of the Little Mouse Does Not Bind GHRH1. , 1999, Endocrinology.
[34] M. Ono,et al. Characterization and Localization of Mouse Hypothalamic Growth Hormone‐Releasing Factor and Effect of Gold Thioglucose‐Induced Hypothalamic Lesions , 1994, Journal of neuroendocrinology.
[35] J. Holst,et al. Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet , 1996, Diabetes Care.
[36] P. Halban,et al. Role of the Prohormone Convertase PC3 in the Processing of Proglucagon to Glucagon-like Peptide 1* , 1997, The Journal of Biological Chemistry.
[37] D. Constam,et al. SPC4/PACE4 regulates a TGFbeta signaling network during axis formation. , 2000, Genes & development.
[38] P. Kitabgi,et al. Evidence That PC2 Is the Endogenous Pro-neurotensin Convertase in rMTC 6-23 Cells and That PC1- and PC2-transfected PC12 Cells Differentially Process Pro-neurotensin (*) , 1996, The Journal of Biological Chemistry.
[39] J. Holst,et al. 1 - Assays for Peptide Products of Somatostatin Gene Expression , 1991 .
[40] S. O’Rahilly,et al. Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. , 1995, The New England journal of medicine.
[41] D. Drucker,et al. Gut adaptation and the glucagon-like peptides , 2002, Gut.
[42] R. Palmiter,et al. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. , 1988, Genes & development.
[43] S. Suhr,et al. Growth hormone-releasing hormone: synthesis and signaling. , 1995, Recent progress in hormone research.
[44] P. Mullis,et al. Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. , 2002, Molecular endocrinology.